CD4 and cryptosporidiosis: Immunocompromised individuals are at the highest risk of morbidity and mortality due to chronic cryptosporidiosis, largely due to the ineffectiveness of anti-Cryptosporidium treatment in patients with low CD4+ cell counts [3,8].